AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (January 12, 2006). doi:10.1152/ajpgi.00460.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/G1261    most recent
00460.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsung, A.
Right arrow Articles by Geller, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsung, A.
Right arrow Articles by Geller, D. A.
Submitted on October 3, 2005
Accepted on January 10, 2006

THE TRANSCRIPTION FACTOR INTERFERON REGULATORY FACTOR-1 MEDIATES LIVER DAMAGE DURING ISCHEMIA-REPERFUSION INJURY

Allan Tsung1, Michael T. Stang1, Atsushi Ikeda1, Nathan D. Critchlow1, Kunihiko Izuishi1, Atsunori Nakao1, Meagan H. Chan1, Geetha Jeyabalan1, John H. Yim1, and David A. Geller1*

1 Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA

* To whom correspondence should be addressed. E-mail: gellerda{at}upmc.edu.

Hepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 minutes of hepatic ischemia, IRF-1 protein expression increased as early as one hour after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared to their wildtype controls. Hepatic I/R injury resulted in marked activation of the MAP kinase JNK in the wildtype, but not IRF-1 knockout mice. The IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C7BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic inducible nitric oxide synthase (iNOS) expression. Since IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. IFN{gamma} and IFN{beta} were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, while TNF{alpha} and IL-1{beta} also induced IRF-1 mRNA to a lesser extent (2-3 fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1 mediated injury involves the activation of JNK, and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.